Relmada Therapeutics Inc’s filing revealed that its Chief Operating Officer Kelly Paul Edward acquired Company’s shares for reported $86060.0 on May 16 ’25. In the deal valued at $0.43 per share,200,000 shares were bought. As a result of this transaction, Kelly Paul Edward now holds 412,295 shares worth roughly $0.33 million.
Then, Shenouda Maged bought 90,000 shares, generating $43,686 in total proceeds. Upon buying the shares at $0.49, the Chief Financial Officer now owns 228,335 shares.
Before that, Shenouda Maged bought 60,000 shares. Relmada Therapeutics Inc shares valued at $31,422 were divested by the Chief Financial Officer at a price of $0.52 per share. As a result of the transaction, Shenouda Maged now holds 288,335 shares, worth roughly $0.23 million.
Mizuho downgraded its Relmada Therapeutics Inc [RLMD] rating to a Neutral from a an Outperform in a research note published on December 05, 2024; the price target was decreased to $1 from $23. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in mid September from “a Hold” to “a Buy”. Goldman also remained covering RLMD and has decreased its forecast on June 05, 2024 with a “Sell” recommendation from previously “Neutral” rating. Truist revised its rating on October 14, 2022. It rated RLMD as “a Hold” which previously was an “a Buy”.
Price Performance Review of RLMD
On Tuesday, Relmada Therapeutics Inc [NASDAQ:RLMD] saw its stock fall -4.15% to $0.79. Over the last five days, the stock has gained 13.61%. Relmada Therapeutics Inc shares have risen nearly 52.35% since the year began. Nevertheless, the stocks have fallen -73.94% over the past one year.
How much short interest is there in Relmada Therapeutics Inc?
A steep rise in short interest was recorded in Relmada Therapeutics Inc stocks on 2025-05-15, dropping by -0.19 million shares to a total of 1.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 1.41 million shares. There was a decline of -15.27%, which implies that there is a negative sentiment for the stock.
